CODX vs NTRS · rev $3.9M vs P/E 18, $32.02B cap
Co-Diagnostics, Inc. Common Stock (CODX) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
NTRS does not have a complete income-statement cache yet.
CODX currently screens at market cap $31.4M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the CODX and NTRS stock pages for the full models.
Not investment advice.